Innovent Biologics (6IB) Q2 2025 Earnings Report
DE:6IB Q2 2025 EPS Results
- Actual EPS
- EUR 0.07
- Consensus EPS
- EUR 0.02
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- -EUR 0.03
DE:6IB Q2 2025 Revenue Results
- Actual Revenue
- EUR 730.59M
- Expected Revenue
- EUR 761.52M
- Beat/Miss
- Missed by -EUR 30.93M
- YoY Revenue Growth
- +49.31%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/27/2025
- Time
- Before Open
- Conference Call
- Wednesday, August 27, 2025
DE:6IB Upcoming Earnings
Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6IB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | 0.15- | 0 | ― | ― |
| Aug 25, 2026 | 2026 (Q2) | 0.060.09 | 0.07 | 37.25% (+0.03) | |
| Mar 26, 2026 | 2025 (Q4) | 0.02-0.00 | 0.02 | -105.56% (-0.03) | |
| Aug 27, 2025 | 2025 (Q2) | 0.020.07 | -0.03 | 312.50% (+0.10) | |
| Mar 26, 2025 | 2024 (Q4) | -0.030.02 | -0.08 | 131.69% (+0.10) | |
| Aug 28, 2024 | 2024 (Q2) | -0.03-0.03 | -0.01 | -166.67% (-0.02) | |
| Mar 20, 2024 | 2023 (Q4) | -0.09-0.08 | -0.11 | 32.38% (+0.04) | |
| Aug 23, 2023 | 2023 (Q2) | -0.09-0.01 | -0.09 | 86.15% (+0.08) | |
| Mar 31, 2023 | 2022 (Q4) | -0.09-0.11 | -0.18 | 37.78% (+0.07) | |
| Aug 25, 2022 | 2022 (Q2) | -0.91-0.09 | -0.11 | 19.75% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed